Histopathology Conference

Overview:

Histopathology has been a keystone of disease diagnosis and prognosis enabling laboratory professionals to examine tissue samples for any pathological changes or abnormalities. This year the conference will discuss digital pathology impact in gynaecologic cytology screening, 2022 WHO classification of thyroid tumors and molecular in neuropathy practice. The conference aims to provide the latest updates, developments and emerging trends in histopathology. 

Key topics:
 

• 2022 WHO classification of thyroid tumors  
• Digital cytology: basics 
• Molecular in neuropathy practice  
• Digital pathology impact in gynaecologic cytology screening  
  
• Biomarker; PDL1, HEr-2 low  

Benefits of attending:

• Discuss the changes in the 5th edition of WHO classification related to the thyroid gland
  
• Review basic principles and prospects of digital cytology in diagnosing, research and training 
  
• Evaluate the role of AI applications and current practice in early detection of cancer 
• Explore the role of PD1 protein and its association with HEr-2 low breast cancer management 
  

Chair:

• Dr Mouza Al Sharhan, Head of Pathology, Dubai Hospital-Dubai Health Authority; President, Emirates Medical Association, Dubai, UAE